SE8304616L - Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering - Google Patents

Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering

Info

Publication number
SE8304616L
SE8304616L SE8304616A SE8304616A SE8304616L SE 8304616 L SE8304616 L SE 8304616L SE 8304616 A SE8304616 A SE 8304616A SE 8304616 A SE8304616 A SE 8304616A SE 8304616 L SE8304616 L SE 8304616L
Authority
SE
Sweden
Prior art keywords
dystrophies
prevention
myopic
burns
retinary
Prior art date
Application number
SE8304616A
Other languages
English (en)
Swedish (sv)
Other versions
SE8304616D0 (sv
Inventor
N M Emanuel
A A Shvedova
L D Smirnov
L V Spirina
L A Katsnelson
Original Assignee
Inst Khim Fiz An Sssr
Mo Nii Glaznykh Bol Vni Khim F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Khim Fiz An Sssr, Mo Nii Glaznykh Bol Vni Khim F filed Critical Inst Khim Fiz An Sssr
Publication of SE8304616D0 publication Critical patent/SE8304616D0/xx
Publication of SE8304616L publication Critical patent/SE8304616L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8304616A 1983-08-17 1983-08-25 Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering SE8304616L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/523,954 US4486440A (en) 1983-08-17 1983-08-17 Retinoprotector for treating intraocular hemorrhage, myopic, chorioretinal dystrophies, congenital retinal dystrophies, retinal burns and prevention of injury in lasercoagulation

Publications (2)

Publication Number Publication Date
SE8304616D0 SE8304616D0 (sv) 1983-08-25
SE8304616L true SE8304616L (sv) 1985-02-26

Family

ID=24087103

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304616A SE8304616L (sv) 1983-08-17 1983-08-25 Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering

Country Status (6)

Country Link
US (1) US4486440A (xx)
JP (1) JPS6061526A (xx)
CH (1) CH658595A5 (xx)
DE (1) DE3330053A1 (xx)
FR (1) FR2551659B1 (xx)
SE (1) SE8304616L (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008102A (en) * 1986-02-26 1991-04-16 York Kenneth K Biocompatible intraocular light-screening compositions and methods of intraocular light screening
US6161770A (en) 1994-06-06 2000-12-19 Sturman; Oded E. Hydraulically driven springless fuel injector
JP3688339B2 (ja) * 1995-02-28 2005-08-24 株式会社ニデック レ−ザ治療装置
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
US6085991A (en) 1998-05-14 2000-07-11 Sturman; Oded E. Intensified fuel injector having a lateral drain passage
RU2362554C2 (ru) * 2007-09-27 2009-07-27 Екатерина Валентиновна Лопатина Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства
TR200904159A1 (tr) 2009-04-17 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Değiştirilmiş salım sağlayan emoksipin formülasyonları.
CN101891677B (zh) * 2010-07-13 2012-07-25 绍兴文理学院 6-甲基-2-乙基-3-羟基吡啶的生产方法
US9614209B2 (en) * 2013-02-25 2017-04-04 The Boeing Company Aircraft including mitigation system for rechargeable batteries
RU2605825C1 (ru) * 2015-12-01 2016-12-27 Виталий Эдуардович Боровиков Раствор для внутривенного и внутримышечного введения на основе этилметилгидроксипиридина сукцината и способ его получения
RU2652891C1 (ru) * 2017-03-16 2018-05-03 Андрей Николаевич Болдырев Салицилат 2-этил-6-метил-3-гидроксипиридина, его сольваты и гидраты и способы их получения
RU2663836C1 (ru) * 2017-12-14 2018-08-10 Акционерное общество "Мадмит трейд" L-Энантиомер 2-этил-6-метил-3-гидроксипиридиния гидроксибутандиоата, обладающий церебропротекторной активностью

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983238A (en) * 1972-10-20 1976-09-28 Sankyo Company Limited Substituted pyridinol-containing compositions and methods for the treatment of coccidiosis

Also Published As

Publication number Publication date
DE3330053C2 (xx) 1988-12-08
CH658595A5 (de) 1986-11-28
JPH0129167B2 (xx) 1989-06-08
FR2551659B1 (fr) 1986-07-04
JPS6061526A (ja) 1985-04-09
SE8304616D0 (sv) 1983-08-25
FR2551659A1 (fr) 1985-03-15
US4486440A (en) 1984-12-04
DE3330053A1 (de) 1985-02-28

Similar Documents

Publication Publication Date Title
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
SE8304616D0 (sv) Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering
AR035533A1 (es) Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
ES2145913T3 (es) Inhibidores de metaloproteasas.
KR920019342A (ko) 골질환 치료제
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
NO994485L (no) Styrt frigivelse av farmasöytiske midler i det fremre kammer i öyet
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
BR9607410A (pt) Soluções farmacêuticas salinas não inorgânicas para administração endonasal
AR004214A1 (es) Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
BR9712308A (pt) Inibidor de catarata secundária
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
KR930019224A (ko) 유산 위험 치료제
DE69011130D1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
NO179472C (no) Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
SE8901149D0 (sv) Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
JP2003055227A (ja) 安定化された組成物
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
ATE52030T1 (de) Arzneimittel fuer die behandlung und verhuetung von leberschaedigungen.
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
WO2000010605A3 (en) Preventives or remedies for eye circulatory failure
RU95101840A (ru) Сложные эфиры циклогексанола и содержащий их фармацевтический препарат